Watch the webinar here.
In this on-demand webinar, expert panelists discuss the potential impact of the new Draft Guidance from the FDA on diversity plans to improve the enrollment of participants from underrepresented racial and ethnic populations in clinical trials, and outline efforts to support the mission of increasing diversity in clinical trials.
This webinar engages a range of stakeholders and discusses the roles of industry, government, advocacy, and patients – to share best practices and discuss strategies to make diversity efforts successful.